Protalix BioTherapeutics (NYSE:PLX) Upgraded at StockNews.com
Protalix BioTherapeutics (NYSE:PLX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a report issued on Wednesday. Separately, HC Wainwright upped their price objective on shares of Protalix BioTherapeutics from $10.00 to $15.00 and gave the stock a “buy” rating in a research report […]
Protalix BioTherapeutics (NYSE:PLX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a report issued on Wednesday. Separately, HC Wainwright upped their price objective on shares of Protalix BioTherapeutics from $10.00 to $15.00 and gave the stock a “buy” rating in a research report […]
